Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 2
2004 2
2005 2
2007 2
2008 1
2010 2
2011 1
2012 2
2014 4
2015 4
2016 1
2017 4
2018 7
2019 3
2020 4
2021 4
2022 3
2023 6
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

53 results

Results by year

Filters applied: . Clear all
Page 1
DNA double-strand break repair pathway regulates PD-L1 expression in cancer cells.
Sato H, Niimi A, Yasuhara T, Permata TBM, Hagiwara Y, Isono M, Nuryadi E, Sekine R, Oike T, Kakoti S, Yoshimoto Y, Held KD, Suzuki Y, Kono K, Miyagawa K, Nakano T, Shibata A. Sato H, et al. Among authors: yoshimoto y. Nat Commun. 2017 Nov 24;8(1):1751. doi: 10.1038/s41467-017-01883-9. Nat Commun. 2017. PMID: 29170499 Free PMC article.
[Radiotherapy and PD-L1 Expression].
Sato H, Okonogi N, Yoshimoto Y, Tamaki T, Suzuki Y. Sato H, et al. Among authors: yoshimoto y. Gan To Kagaku Ryoho. 2019 May;46(5):845-849. Gan To Kagaku Ryoho. 2019. PMID: 31189801 Review. Japanese.
Melanoma and immunotherapy bridge 2015 : Naples, Italy. 1-5 December 2015.
Nanda VGY, Peng W, Hwu P, Davies MA, Ciliberto G, Fattore L, Malpicci D, Aurisicchio L, Ascierto PA, Croce CM, Mancini R, Spranger S, Gajewski TF, Wang Y, Ferrone S, Vanpouille-Box C, Wennerberg E, Pilones KA, Formenti SC, Demaria S, Tang H, Wang Y, Fu YX, Dummer R, Puzanov I, Tarhini A, Chauvin JM, Pagliano O, Fourcade J, Sun Z, Wang H, Sanders C, Kirkwood JM, Chen THT, Maurer M, Korman AJ, Zarour HM, Stroncek DF, Huber V, Rivoltini L, Thurin M, Rau T, Lugli A, Pagès F, Camarero J, Sancho A, Jommi C, de Coaña YP, Wolodarski M, Yoshimoto Y, Gentilcore G, Poschke I, Masucci GV, Hansson J, Kiessling R, Scognamiglio G, Sabbatino F, Marino FZ, Anniciello AM, Cantile M, Cerrone M, Scala S, D’alterio C, Ianaro A, Cirin G, Liguori G, Bott G, Chapman PB, Robert C, Larkin J, Haanen JB, Ribas A, Hogg D, Hamid O, Testori A, Lorigan P, Sosman JA, Flaherty KT, Yue H, Coleman S, Caro I, Hauschild A, McArthur GA, Sznol M, Callahan MK, Kluger H, Postow MA, Gordan R, Segal NH, Rizvi NA, Lesokhin A, Atkins MB, Burke MM, Ralabate A, Rivera A, Kronenberg SA, Agunwamba B, Ruisi M, Horak C, Jiang J, Wolchok J, Ascierto PA, Liszkay G, Maio M, Mandalà M, Demidov L, Stoyakovskiy D, Thomas L, de la … See abstract for full author list ➔ Nanda VGY, et al. Among authors: yoshimoto y. J Transl Med. 2016 Jul 25;14(1):65. doi: 10.1186/s12967-016-0791-2. J Transl Med. 2016. PMID: 27461275 Free PMC article.
Combination of oligo-fractionated irradiation with nivolumab can induce immune modulation in gastric cancer.
Mimura K, Ogata T, Nguyen PHD, Roy S, Kared H, Yuan YC, Fehlings M, Yoshimoto Y, Yoshida D, Nakajima S, Sato H, Machida N, Yamada T, Watanabe Y, Tamaki T, Fujikawa H, Inokuchi Y, Hayase S, Hanayama H, Saze Z, Katoh H, Takahashi F, Oshima T, Goel A, Nardin A, Suzuki Y, Kono K. Mimura K, et al. Among authors: yoshimoto y. J Immunother Cancer. 2024 Jan 30;12(1):e008385. doi: 10.1136/jitc-2023-008385. J Immunother Cancer. 2024. PMID: 38290769 Free PMC article.
In Reply to Minhas and Tran.
Okonogi N, Suzuki Y, Sato H, Oike T, Yoshimoto Y, Mimura K, Noda SE, Okamoto M, Tamaki T, Morokoshi Y, Hasegawa S, Ohgaki H, Yokoo H, Nakano T. Okonogi N, et al. Among authors: yoshimoto y. Int J Radiat Oncol Biol Phys. 2019 May 1;104(1):223-224. doi: 10.1016/j.ijrobp.2019.01.086. Int J Radiat Oncol Biol Phys. 2019. PMID: 30967232 No abstract available.
Phase I/II clinical trial of nivolumab in combination with oligo-fractionated irradiation for unresectable advanced or recurrent gastric cancer.
Mimura K, Ogata T, Yoshimoto Y, Yoshida D, Nakajima S, Sato H, Machida N, Yamada T, Watanabe Y, Tamaki T, Fujikawa H, Inokuchi Y, Hayase S, Hanayama H, Saze Z, Katoh H, Takahashi F, Oshima T, Suzuki Y, Kono K. Mimura K, et al. Among authors: yoshimoto y. Commun Med (Lond). 2023 Aug 15;3(1):111. doi: 10.1038/s43856-023-00343-4. Commun Med (Lond). 2023. PMID: 37582945 Free PMC article.
Anti-PD-1 monoclonal antibody-resistant esophageal squamous cell carcinoma showing the abscopal effect: A case report with T-cell receptor/B-cell receptor repertoire analysis.
Takehara Y, Mimura K, Suzuki Y, Watanabe Y, Yoshimoto Y, Saze Z, Sato H, Tamaki T, Kono K. Takehara Y, et al. Among authors: yoshimoto y. Cancer Rep (Hoboken). 2023 Jul;6(7):e1832. doi: 10.1002/cnr2.1832. Epub 2023 May 11. Cancer Rep (Hoboken). 2023. PMID: 37165926 Free PMC article.
Mutation Analysis of Radioresistant Early-Stage Cervical Cancer.
Oike T, Sekiguchi Y, Yoshimoto Y, Oike T, Ando K, Gu W, Sasaki Y, Tokino T, Iwase A, Ohno T. Oike T, et al. Among authors: yoshimoto y. Int J Mol Sci. 2021 Dec 21;23(1):51. doi: 10.3390/ijms23010051. Int J Mol Sci. 2021. PMID: 35008475 Free PMC article.
53 results